Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, which will work to reduce health disparities by addressing the barriers to representation for minorities in clinical trials and enhancing the diversity of clinical researchers.
The initiative will expand Columbia’s Community Health Workers Program network to connect with underserved populations and create culturally sensitive engagement tools. The effort also will include identifying new ways to make clinical trials more accessible through telemedicine, wearable technology, and home visits. By doing this, the Initiate hopes to bring participation from racial and ethnic minorities in clinical trials in line with their numbers in the population.
Pfizer will provide a three-year, $10 million grant to Columbia to help establish and expand the Initiative.
Read the full article at neighbors.columbia.edu/news.